Conversations in Clinical Trial Readiness

Atul Mahableshwarkar, M.D., DFAPA, joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss clinical trial methodology. A self-described “trial nerd,” Atul illuminates the make-or-break role methodology plays in a trial’s success and shares his advice and best practices for making positive outcomes possible.

Jennifer Brandl joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the feasibility and pros and cons of virtual site initiation visits. A clinical operations expert with a passion for data science, Jennifer shares her experience transitioning from pre-clinical to clinical research and her confidence that data can change the world.

Ahmed Hamouda joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the opportunity Africa and the Middle East represent for clinical trials right now. A clinical research expert with truly global experience, Ahmed addresses the challenges sponsors face when entering new markets and explains why Africa and the Middle East are worth investing in.

Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical operations specialist and a strong advocate for data diversity, Peju shares her insight into the health sciences industry, evaluates opportunities for improvement, and illuminates the path forward.

Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the growing complexity in clinical trial protocols. The Director of the Tufts Center for the Study of Drug Development and a Research Professor at the Tufts University School of Medicine, Ken shares his insights on protocol design along with strategic advice on how to design for maximum impact.

Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss effective management of sites and teams through arduous clinical trials. Rebecca shares how she’s kept her team motivated and productive in spite of the added burdens imposed by the pandemic, and why she’s excited about the future of the industry.

Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials. The founder and CEO of OncoBay Clinical, Krystyna shares her efforts to break the mold when it comes to cancer research, and some obstacles she’s encountered and successes she’s earned along the way.

Paul Evans of Velocity Clinical Research joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss best practices for sites making the shift toward decentralized trials. He shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to make the call on whether virtual will be cost saving, and how he pictures the future of his 12 (and counting) sites.

Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, about how research site management is changing in the face of the pandemic. Mary’s more than 20 years of diverse experience in the industry position her well to provide insight from a variety of perspectives, including management, marketing, and the coordinator’s role. She shares the new cornerstones of success that have emerged in the face of COVID, and illuminates ways we can all work together to help research sites deliver.

R’Kes Starling talks with Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, about how decentralized clinical trials (DCTs) can expand access to clinical trials and promote patient participation. He shares the personal experiences that motivated him to found Reveles, recounts a poignant story of a patient who was empowered and given hope through DCT, and describes how he and his company are working to overcome the hurdles on the path to DCT.

Anyone wondering whether DCT is right for them will appreciate R’Kes’s take, which unites his personal and professional experiences in a perspective that is both empathetic and firmly grounded in reality.